glp-1 target Dr. Stephanie's GLP-Wonder, a for Appetite & Metabolism Support Supergut GLP Oral GLP-1s and injectable GLP-1s

Clinical practice

Nevertheless, concerning case reports and retrospective studies have emerged in 2023 of undigested gastric contents in sedated/anaesthetised patients undergoing elective endoscopy with unprotected airways: Klein and Hobai (2023) published a case report of a patient taking semaglutide for weight loss who experienced pulmonary aspiration from undigested food content identified during routine gastroscopy, despite fasting 18hr prior to the procedure

However, along with the rapid titration schedule came gastrointestinal side effects, especially nausea and vomiting, which were the most common reason for discontinuation

Retrieved from Tchang, B

Gastrointest Endos Clin North Am